Search results
AbbVie Raises Earnings Guidance Even as Humira Sales Continue to Drop
Barrons.com· 4 days agoAbbVie reports better-than-expected adjusted earnings in the first quarter.Read the full article
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
Motley Fool via Yahoo Finance· 3 days agoBy almost any measure, AbbVie (NYSE: ABBV) shares should have risen Friday. The pharmaceutical giant...
AbbVie Inc (ABBV) Q1 2024 Earnings: Adjusted EPS Tops Estimates
Guru Focus· 4 days agoOn April 26, 2024, AbbVie Inc (ABBV, Financial) released its 8-K filing, detailing the financial outcomes for the first quarter ended March 31, 2024. The pharmaceutical giant ...
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 days agoImage source: The Motley Fool. AbbVie (NYSE: ABBV) Q1 2024 Earnings Call Apr 26, 2024, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
Drugmaker AbbVie expects Humira volume erosion to worsen
Reuters via Yahoo News· 4 days ago(Reuters) -AbbVie expects a drop in sales volumes of its blockbuster arthritis drug Humira to deepen...
AbbVie First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 2 days agoAbbVie (NYSE:ABBV) First Quarter 2024 Results Key Financial Results Revenue: US$12.3b (flat on 1Q...
AbbVie earnings beat by $0.04, revenue topped estimates
Investing.com· 4 days agoAbbVie earnings beat by $0.04, revenue topped estimates
AbbVie Lifts Outlook After 1Q Revenue Unexpectedly Rises
Market Watch· 4 days agoAbbVie raised its annual adjusted earnings guidance after revenue unexpectedly rose in the first quarter as lower sales of Humira were offset with gains elsewhere. The drugmaker ...
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View
Zacks via Yahoo Finance· 3 days agoAbbVie Inc. ABBV reported adjusted earnings of $2.31 per share for first-quarter 2024, beating the...
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 4 days agoSales of the pharma giant's newer drugs are offsetting its Humira losses.